This systematic review and network meta-analysis assessed the impact of mind-body exercises, including Yijinjing, meditation, and Liuzijue, compared to conventional care in patients with chronic heart failure. The analysis synthesized data from twenty-eight randomized controlled trials to evaluate effects on quality of life, cardiopulmonary endurance, cardiac systolic function, cardiac load indicators, and exercise tolerance.
The authors observed that Yijinjing demonstrated significant superiority over conventional care across most measured outcomes, including quality of life, endurance, and cardiac function. In contrast, meditation showed the highest potential probability for improving exercise tolerance, though the analysis noted a lack of statistical significance for this specific indicator compared to other interventions.
The study highlights that while certain indicators showed significant benefits, others did not reach statistical significance, indicating variability in treatment effects. The authors note limitations regarding the lack of statistical significance in specific indicators like exercise tolerance. The certainty of evidence based on CINeMA was rated as moderate. The authors suggest that future intervention designs should focus on the regulatory effects of mind-body integration on kinesiophobia to develop more precise and long-term validated rehabilitation strategies.
View Original Abstract ↓
Background and objectiveMind–body exercise (MBE) has emerged as a vital adjunctive modality in the rehabilitation of chronic heart failure (CHF). However, the relative advantages of various MBE types in improving functional capacity and quality of life (QoL) remain elusively defined. This study aimed to compare the therapeutic efficacy of different MBEs on clinical outcomes in CHF patients using a network meta-analysis (NMA).MethodsA systematic search was conducted across databases including PubMed, Embase, Web of Science, and the Cochrane Library for randomized controlled trials (RCTs) investigating MBE interventions in CHF, spanning from database inception to January 12, 2026. Two researchers independently performed literature screening, data extraction, and risk of bias assessment (RoB 2.0). R software was utilized for network meta-analysis, SUCRA (Surface Under the Cumulative Ranking Curve) ranking, cluster analysis, and Egger’s test for publication bias. The certainty of evidence was evaluated using the CINeMA (Confidence in Network Meta-Analysis) framework.ResultsTwenty-eight RCTs were ultimately included. The NMA results indicated that Yijinjing was significantly superior to conventional care in improving quality of life (MLHFQ), cardiopulmonary endurance (Peak VO2), and cardiac systolic function (LVEF), as well as in reducing cardiac load indicators (NT-proBNP). Furthermore, Yijinjing yielded the highest SUCRA values (0.858–1.000) across these outcomes, demonstrating a high potential intervention probability. Regarding the enhancement of exercise tolerance (6MWD), Meditation showed the highest potential probability (SUCRA = 0.675); however, pairwise comparisons revealed no statistically significant differences between any MBE and conventional care (p > 0.05). Cluster analysis further confirmed a synergistic trend of Yijinjing, Liuzijue, and Meditation in enhancing both QoL and exercise endurance. No significant publication bias was detected by Egger’s test for any outcome (p > 0.05). The certainty of evidence based on CINeMA was rated as Moderate.ConclusionBased on moderate-certainty evidence, Yijinjing shows the highest potential probability for promoting cardiac functional recovery and enhancing quality of life in CHF patients, while meditation particularly of the movement-integrated type shows potential advantages in strengthening functional exercise tolerance. Given the lack of statistical significance in certain indicators (e.g., 6MWD), future intervention designs should focus on the regulatory effects of mind–body integration on kinesiophobia to develop more precise and long-term validated rehabilitation strategies.Systematic review registrationwww.crd.york.ac.uk/prospero, CRD420261308623.